Bioscience Animal Health PCL (BKK:BIS)
Thailand · Delayed Price · Currency is THB 2.160
0.00 (0.00%)
Sep 3, 2026, 12:03 PM ICT
BKK:BIS Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 678 | 615 | 923 | 1,539 | 2,496 | - | |
Market Cap Growth | -15.63% | -33.33% | -40.00% | -38.37% | - | - |
Enterprise Value | 445 | 329 | 855 | 1,434 | 2,332 | - |
Last Close Price | 2.16 | 1.74 | 2.45 | 3.93 | 6.27 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.98 | 16.00 | 14.19 | 30.34 | 44.65 | - |
PS Ratio | 0.30 | 0.27 | 0.40 | 0.64 | 1.13 | - |
PB Ratio | 0.85 | 0.77 | 1.13 | 1.95 | 3.25 | - |
P/TBV Ratio | 0.86 | 0.79 | 1.16 | 1.99 | 3.30 | - |
P/FCF Ratio | 8.81 | 2.25 | 9.37 | - | - | - |
P/OCF Ratio | 8.41 | 2.23 | 8.84 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.20 | 0.15 | 0.37 | 0.60 | 1.05 | - |
EV/EBITDA Ratio | 6.86 | 4.57 | 7.77 | 17.81 | 26.52 | - |
EV/EBIT Ratio | 9.34 | 5.85 | 9.01 | 21.01 | 30.83 | - |
EV/FCF Ratio | 5.78 | 1.20 | 8.68 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.07 | 0.01 | 0.01 | 1.17 |
Debt / EBITDA Ratio | 0.11 | 0.08 | 0.50 | 0.08 | 0.07 | 2.75 |
Debt / FCF Ratio | 0.09 | 0.02 | 0.57 | - | - | 16.87 |
Net Debt / Equity Ratio | -0.30 | -0.43 | -0.16 | -0.11 | -0.16 | 0.90 |
Net Debt / EBITDA Ratio | -3.96 | -4.73 | -1.16 | -1.13 | -1.36 | 2.21 |
Net Debt / FCF Ratio | -3.14 | -1.24 | -1.29 | 3.17 | 2.53 | 12.95 |
Asset Turnover | 1.81 | 1.80 | 1.87 | 2.09 | 2.21 | 2.29 |
Inventory Turnover | 6.83 | 7.58 | 6.45 | 6.62 | 7.43 | 8.08 |
Quick Ratio | 1.70 | 1.76 | 1.63 | 1.42 | 1.80 | 0.79 |
Current Ratio | 2.53 | 2.36 | 2.42 | 2.41 | 2.79 | 1.19 |
Return on Equity (ROE) | 4.69% | 5.31% | 8.93% | 6.78% | 11.53% | 28.61% |
Return on Assets (ROA) | 2.42% | 2.80% | 4.78% | 3.69% | 4.72% | 6.92% |
Return on Invested Capital (ROIC) | 7.08% | 7.64% | 10.63% | 8.06% | 10.31% | 16.03% |
Return on Capital Employed (ROCE) | 5.80% | 6.90% | 11.40% | 8.50% | 9.70% | 30.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.00% | 6.25% | 7.04% | 3.30% | 2.24% | - |
FCF Yield | 11.35% | 44.54% | 10.67% | -1.86% | -1.89% | - |
Dividend Yield | 12.50% | 6.88% | 5.72% | 2.80% | 1.95% | - |
Payout Ratio | 111.60% | 138.75% | 57.93% | 63.48% | 195.01% | 30.39% |
Buyback Yield / Dilution | - | - | - | -10.71% | -28.91% | -25.24% |
Total Shareholder Return | 12.50% | 6.88% | 5.72% | -7.92% | -26.96% | -25.24% |